(Q24244026)

Vivian Welch

6

0 references

George Wells

8

George A Wells

0 references

Lara J Maxwell

2

Lara Maxwell

0 references

Marc C. Hochberg

7

Marc C Hochberg

0 references

Tanveer Towheed

1

Tanveer Towheed

0 references

author name string

Tassos P Anastassiades

3

0 references

JB Houpt

Cochrane Database of Systematic Reviews

5

0 references

publication date

20 April 2005

0 references

published in

0 references

cites work

Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Glucosamine sulfate in osteoarthritis of the knee.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Randomised, Double-Blind, Parallel, Placebo-Controlled Study of Oral Glucosamine, Methylsulfonylmethane and their Combination in Osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

The effect of glucosamine supplementation on people experiencing regular knee pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Acute interstitial nephritis induced by glucosamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Effects of oral glucosamine sulphate on serum glucose and insulin during an oral glucose tolerance test of subjects with osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Glucosamine sulfate for osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Osteoarthritis: new insights. Part 1: the disease and its risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Celecoxib for rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Glucosamine sulphate and osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Sulfate could mediate the therapeutic effect of glucosamine sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Immediate-hypersensitivity reaction to glucosamine sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Why are clinical trials of glucosamine no longer uniformly positive?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

The neglect of glucosamine as a treatment for osteoarthritis--a personal perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Effects of glucosamine infusion on insulin secretion and insulin action in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Use of 3H-glucosamine and 35S-sulfate with cultured human chondrocytes to determine the effect of glucosamine concentration on formation of chondroitin sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Oral glucosamine for 6 weeks at standard doses does not cause or worsen insulin resistance or endothelial dysfunction in lean or obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Oral glucosamine in doses used to treat osteoarthritis worsens insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Published trials of nonmedicinal and noninvasive therapies for hip and knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Naturocetic (glucosamine and chondroitin sulfate) compounds as structure-modifying drugs in the treatment of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

The effect of glucosamine-chondroitin supplementation on glycosylated hemoglobin levels in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

N-acetylglucosamine prevents IL-1 beta-mediated activation of human chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Rofecoxib (Vioxx) voluntarily withdrawn from market

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Glucosamine use in pregnancy: an evaluation of pregnancy outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Effect of glucosamine supplementation on fasting and non-fasting plasma glucose and serum insulin concentrations in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the knee, with an emphasis on trial methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Published meta-analyses of pharmacological therapies for osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Current status of glucosamine therapy in osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Articular cartilage pharmacology: I. In vitro studies on glucosamine and non steroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Glucosamine for pain in osteoarthritis: why do trial results differ?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Guidelines for the medical management of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Guidelines for the medical management of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

Glucosamine and chondroitin for treating symptoms of osteoarthritis: evidence is widely touted but incomplete

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

7 January 2021

Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

7 January 2021

Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

7 January 2021

Costs and outcomes in rheumatoid arthritis and osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

7 January 2021

Glucosamine sulphate and osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

7 January 2021

Glucosamine sulphate and osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

1 reference

7 January 2021

Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

7 January 2021

Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

7 January 2021

Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

1 reference

7 January 2021

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

7 January 2021

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002946.PUB2

7 January 2021